- Report
- August 2026
- 183 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 178 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- May 2026
- 154 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- February 2026
- 90 Pages
Canada, Global
From €2590EUR$2,850USD£2,226GBP
From €2590EUR$2,850USD£2,226GBP
- Report
- November 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- October 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,242GBP
- Report
- April 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,242GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- May 2026
- 672 Pages
Global
From €3271EUR$3,600USD£2,812GBP
- Report
- April 2026
- 93 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- November 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- May 2026
- 150 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- November 2025
- 70 Pages
Middle East, Africa
From €3135EUR$3,450USD£2,695GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3589EUR$3,950USD£3,085GBP
- Report
- November 2025
- 100 Pages
Europe
From €3589EUR$3,950USD£3,085GBP

The Genomics Artificial Intelligence (AI) market is a rapidly growing sector of the genomics industry. It is focused on the development of AI-based solutions to enable the analysis of large-scale genomic data. These solutions are used to identify genetic variants associated with diseases, to develop personalized treatments, and to improve the accuracy of diagnostics. AI-based solutions are also used to identify novel drug targets and to develop new drugs.
The Genomics AI market is driven by the increasing availability of genomic data, the need for more accurate and personalized treatments, and the growing demand for AI-based solutions. The market is expected to continue to grow in the coming years, as more genomic data is collected and AI-based solutions become more widely adopted.
Some companies in the Genomics AI market include Illumina, BGI, Thermo Fisher Scientific, Genomics plc, and DNAnexus. Show Less Read more